Cargando…

Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)

INTRODUCTION: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. METHODS: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Raul, Guerra, Paula, Rocha, Anabela, Correia, Miguel, Ferreira, Ricardo, Fonseca, Jorge, Lima, Eduardo, Oliveira, António, Vargas Gomes, Marta, Ramos, Diogo, Andreozzi, Valeska, Santos, Marisa D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521323/
https://www.ncbi.nlm.nih.gov/pubmed/37767305
http://dx.doi.org/10.1159/000526059
_version_ 1785110104776900608
author Silva, Raul
Guerra, Paula
Rocha, Anabela
Correia, Miguel
Ferreira, Ricardo
Fonseca, Jorge
Lima, Eduardo
Oliveira, António
Vargas Gomes, Marta
Ramos, Diogo
Andreozzi, Valeska
Santos, Marisa D.
author_facet Silva, Raul
Guerra, Paula
Rocha, Anabela
Correia, Miguel
Ferreira, Ricardo
Fonseca, Jorge
Lima, Eduardo
Oliveira, António
Vargas Gomes, Marta
Ramos, Diogo
Andreozzi, Valeska
Santos, Marisa D.
author_sort Silva, Raul
collection PubMed
description INTRODUCTION: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. METHODS: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluation. Inclusion criteria comprised patients with SBS/CIF, aged ≥1 year, with stable parenteral nutrition (PN). Data collection included patient chart review over a 12-month period and patient/caregiver self-report and SF-36/PedsQL™ questionnaires. Main endpoints comprised clinical and PN characterization, healthcare resource use (HRU), direct costs, and patient QoL. RESULTS: Thirty-one patients were included (11 adults and 20 children). Patients' mean age (standard deviation [SD]) was 57.9 (14.3) years in adults and 7.5 (5.0) years in children, with a mean time since diagnosis of 10.2 (5.9) and 6.6 (4.2) years, respectively. PN was administered for a mean of 5.2 and 6.6 days/week in adults and children, respectively; home PN occurred in 81.8% of adults and 90.0% of children for a mean of 9.6 and 10.8 months/year, respectively. The mean annual number of hospitalizations was 1.9 and 2.0 which lasted for a mean of 34.0 and 29.4 days in adults and children, respectively. Twenty-one and forty hospitalization episodes were reported in adults and children, respectively, of which 71.4% and 85.0% were due to catheter-related complications. Mean annual direct costs per patient amounted to 47,857.53 EUR in adults and 74,734.50 EUR in children, with PN and hospitalizations as the main cost-drivers. QoL assessment showed a clinically significant impaired physical component in adults and a notable deterioration in the school functioning domain in children. CONCLUSION: In Portugal, SBS/CIF patient management is characterized by a substantial therapeutic burden and HRU, translating into high direct costs and a substantial impairment of the adults' physical function and children's school functioning.
format Online
Article
Text
id pubmed-10521323
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-105213232023-09-27 Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) Silva, Raul Guerra, Paula Rocha, Anabela Correia, Miguel Ferreira, Ricardo Fonseca, Jorge Lima, Eduardo Oliveira, António Vargas Gomes, Marta Ramos, Diogo Andreozzi, Valeska Santos, Marisa D. GE Port J Gastroenterol Research Article INTRODUCTION: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. METHODS: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluation. Inclusion criteria comprised patients with SBS/CIF, aged ≥1 year, with stable parenteral nutrition (PN). Data collection included patient chart review over a 12-month period and patient/caregiver self-report and SF-36/PedsQL™ questionnaires. Main endpoints comprised clinical and PN characterization, healthcare resource use (HRU), direct costs, and patient QoL. RESULTS: Thirty-one patients were included (11 adults and 20 children). Patients' mean age (standard deviation [SD]) was 57.9 (14.3) years in adults and 7.5 (5.0) years in children, with a mean time since diagnosis of 10.2 (5.9) and 6.6 (4.2) years, respectively. PN was administered for a mean of 5.2 and 6.6 days/week in adults and children, respectively; home PN occurred in 81.8% of adults and 90.0% of children for a mean of 9.6 and 10.8 months/year, respectively. The mean annual number of hospitalizations was 1.9 and 2.0 which lasted for a mean of 34.0 and 29.4 days in adults and children, respectively. Twenty-one and forty hospitalization episodes were reported in adults and children, respectively, of which 71.4% and 85.0% were due to catheter-related complications. Mean annual direct costs per patient amounted to 47,857.53 EUR in adults and 74,734.50 EUR in children, with PN and hospitalizations as the main cost-drivers. QoL assessment showed a clinically significant impaired physical component in adults and a notable deterioration in the school functioning domain in children. CONCLUSION: In Portugal, SBS/CIF patient management is characterized by a substantial therapeutic burden and HRU, translating into high direct costs and a substantial impairment of the adults' physical function and children's school functioning. S. Karger AG 2022-09-08 /pmc/articles/PMC10521323/ /pubmed/37767305 http://dx.doi.org/10.1159/000526059 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
spellingShingle Research Article
Silva, Raul
Guerra, Paula
Rocha, Anabela
Correia, Miguel
Ferreira, Ricardo
Fonseca, Jorge
Lima, Eduardo
Oliveira, António
Vargas Gomes, Marta
Ramos, Diogo
Andreozzi, Valeska
Santos, Marisa D.
Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
title Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
title_full Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
title_fullStr Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
title_full_unstemmed Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
title_short Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
title_sort clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure in portugal (parenteral study)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521323/
https://www.ncbi.nlm.nih.gov/pubmed/37767305
http://dx.doi.org/10.1159/000526059
work_keys_str_mv AT silvaraul clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT guerrapaula clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT rochaanabela clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT correiamiguel clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT ferreiraricardo clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT fonsecajorge clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT limaeduardo clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT oliveiraantonio clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT vargasgomesmarta clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT ramosdiogo clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT andreozzivaleska clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy
AT santosmarisad clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy